Founded in 2007, PanTheryx is a medical nutrition company based in Boulder, Colorado USA, and is dedicated to improving global health and quality of life through innovative life science. Utilizing its broad-based proprietary technology platform, PanTheryx is focused on the research, development and commercialization of medical nutrition products targeting the gastrointestinal microbiome. The company’s lead product targets acute pediatric infectious diarrhea, a leading cause of death worldwide among children under the age of five.
Core to our business strategy is scientific excellence and the development of an extensive intellectual property (IP) position, to ensure the sustainability of the business. As part of the overall IP strategy, we have filed for patent protection globally and have retained certain aspects of our technology as trade secret. Overall, we have begun receiving issued patents, and we expect strong patent coverage and trade secret protection.
The company has conducted three open-label clinical trials which have demonstrated the safety and efficacy of its products. Additional clinical trials are currently underway with key opinion leaders and at distinguished hospitals in multiple geographies.
Finally, partnerships are an important part of our company’s strategy going forward. In particular, we look to leverage the sales, marketing and distribution infrastructures of leading pharmaceutical and consumer healthcare company’s. We have begun launching our products in multiple markets around the world.